Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug

New Delhi, July 04, 2024.

Zydus Lifesciences on Thursday said it has received tentative approval from the US health regulator to market its generic Azilsartan Medoxomil tablets used to treat high blood pressure.

The tentative approval by the US Food and Drug Administration (USFDA) is for Azilsartan Medoxomil tablets of strengths 40 mg and 80 mg, Zydus Lifesciences said in a regulatory filing.

The drug will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ – II, it added.